Gefitinib Impurity III | CAS 95-76-1 - Request Quote
Gefitinib Impurity III
| SZ CAT No: | SZ-G018012 |
| CAS No | 95-76-1 |
| Mol.F. | C6H5Cl2N |
| Mol.Wt. | 162 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gefitinib Impurity III is chemically 3,4-Dichloroaniline. Gefitinib Impurity III is supplied with detailed characterization data compliant with regulatory guideline. Gefitinib Impurity III can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gefitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 95-76-1
Purchase 95-76-1
Order 95-76-1
Enquire 95-76-1
price of 95-76-1
95-76-1 Supplier
95-76-1 Manufacturer
95-76-1 Exporter
buy high quality Gefitinib Impurity III
Purchase Gefitinib Impurity III
Gefitinib Impurity III suppliers
Gefitinib Impurity III manufacturers
Gefitinib Impurity III price
Order Gefitinib Impurity III
Enquire Gefitinib Impurity III
Gefitinib Impurity III cost
Gefitinib Impurity III Supplier
Gefitinib Impurity III Distributor
Gefitinib Impurity III for Method Validation
Gefitinib Reference Standard
Gefitinib Impurity III for ANDA Filing
Gefitinib Impurity III for Forced Degradation Studies
Gefitinib Impurity III Identification Standards
Gefitinib Impurity III for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


